CVS Beats EPS Estimates, Losses Loom

CVS Health reported mixed fourth-quarter earnings, beating estimates but showing challenges in key areas.CVS Health (CVS 14.56%), a leading integrated healthcare and pharmacy solutions provider, released its fourth-quarter 2024 earnings on February 12, 2025. The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of$0.91 by 30.8%. Total revenue reached $97.7 billion, exceeding the$97.1 billion forecast and marking a year-over-year increase of 4.2%. ...